Shares of Novacyt S.A. (LON:NCYT – Get Free Report) traded up 5% during trading on Wednesday . The company traded as high as GBX 72.36 ($0.89) and last traded at GBX 71.40 ($0.88). 137,563 shares traded hands during trading, an increase of 90% from the average session volume of 72,583 shares. The stock had previously closed at GBX 68 ($0.84).
Novacyt Stock Up 5.0 %
The business’s 50 day simple moving average is GBX 48.89 and its 200 day simple moving average is GBX 52.78. The company has a quick ratio of 4.46, a current ratio of 5.09 and a debt-to-equity ratio of 0.36. The company has a market capitalization of £50.43 million, a PE ratio of -198.33 and a beta of -1.73.
Novacyt Company Profile
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Featured Articles
- Five stocks we like better than Novacyt
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- High-Yield Texas Instruments Could Hit New Highs Soon
- 3 Warren Buffett Stocks to Buy Now
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What Does Downgrade Mean in Investing?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.